ENTRESTO Sacubitril Valsartan Angiotensin Receptor Neprilysin Inhibitor 50mg Tablet 28's
Generic Name: Sacubitril + Valsartan
Brand Name: ENTRESTO
Strength: 50 mg
Quantity: 28 tablets
Type: Tablet
Philippines FDA Registration Number: DR-XY45112
Product Description:
ENTRESTO 50 mg Tablet is a combination of Sacubitril and Valsartan, classified as an angiotensin receptor neprilysin inhibitor (ARNI). It is used to manage heart failure with reduced ejection fraction (HFrEF), improving heart function and reducing the risk of cardiovascular death and hospitalization. ENTRESTO provides a dual mechanism of action that enhances natriuretic peptides while blocking harmful effects of angiotensin II
Original: $204.43
-70%$204.43
$61.33More Images
ENTRESTO Sacubitril Valsartan Angiotensin Receptor Neprilysin Inhibitor 50mg Tablet 28's
Generic Name: Sacubitril + Valsartan
Brand Name: ENTRESTO
Strength: 50 mg
Quantity: 28 tablets
Type: Tablet
Philippines FDA Registration Number: DR-XY45112
Product Description:
ENTRESTO 50 mg Tablet is a combination of Sacubitril and Valsartan, classified as an angiotensin receptor neprilysin inhibitor (ARNI). It is used to manage heart failure with reduced ejection fraction (HFrEF), improving heart function and reducing the risk of cardiovascular death and hospitalization. ENTRESTO provides a dual mechanism of action that enhances natriuretic peptides while blocking harmful effects of angiotensin II
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Generic Name: Sacubitril + Valsartan
Brand Name: ENTRESTO
Strength: 50 mg
Quantity: 28 tablets
Type: Tablet
Philippines FDA Registration Number: DR-XY45112
Product Description:
ENTRESTO 50 mg Tablet is a combination of Sacubitril and Valsartan, classified as an angiotensin receptor neprilysin inhibitor (ARNI). It is used to manage heart failure with reduced ejection fraction (HFrEF), improving heart function and reducing the risk of cardiovascular death and hospitalization. ENTRESTO provides a dual mechanism of action that enhances natriuretic peptides while blocking harmful effects of angiotensin II
